These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2908520)

  • 1. Agglutinogens and fimbriae of Bordetella pertussis.
    Ashworth LA; Robinson A; Funnell S; Gorringe AR; Irons LI; Seabrook RN
    Tokai J Exp Clin Med; 1988; 13 Suppl():203-10. PubMed ID: 2908520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release and purification of fimbriae from Bordetella pertussis.
    Irons LI; Ashworth LA; Robinson A
    Dev Biol Stand; 1985; 61():153-63. PubMed ID: 2872101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.
    Cowell JL; Zhang JM; Urisu A; Suzuki A; Steven AC; Liu T; Liu TY; Manclark CR
    Infect Immun; 1987 Apr; 55(4):916-22. PubMed ID: 2881893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Bordetella pertussis agglutinogen 2 and fimbriae.
    Carter EJ; Preston NW
    J Med Microbiol; 1984 Aug; 18(1):87-94. PubMed ID: 6146723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and preliminary characterization of agglutinogen 3 from Bordetella pertussis.
    Fredriksen JH; Frøholm LO; Paulsen BS
    Dev Biol Stand; 1985; 61():187-96. PubMed ID: 2872104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The location of surface antigens of Bordetella pertussis by immuno-electron microscopy.
    Ashworth LA; Dowsett AB; Irons LI; Robinson A
    Dev Biol Stand; 1985; 61():143-51. PubMed ID: 2872100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-electronmicroscopy of fimbriae-like structures on Bordetella pertussis serotype 1.3.
    Fredriksen JH; Namork E; Frøholm LO
    J Med Microbiol; 1988 Apr; 25(4):285-8. PubMed ID: 2895814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of antigenic domains on the major subunits of Bordetella pertussis serotype 2 and 3 fimbriae.
    Pearce AM; Seabrook RN; Irons LI; Ashworth LA; Atkinson T; Robinson A
    Microbiology (Reading); 1994 Jan; 140 ( Pt 1)():205-11. PubMed ID: 7512870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities].
    Atakan Ablay P; Ozcengiz E
    Mikrobiyol Bul; 2007 Jan; 41(1):11-20. PubMed ID: 17427548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reproducibility of Fim2 and Fim3 antigens determination in Bordetella pertussis by serotyping method].
    Zawadka M; Moskala B; Letowska I; Mosiej E; Krysztopa-Grzybowska K; Lutyńska A
    Med Dosw Mikrobiol; 2013; 65(3):171-9. PubMed ID: 24432556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of the three major agglutinogens of Bordetella pertussis by immuno-electronmicroscopy.
    Preston NW; Zorgani AA; Carter EJ
    J Med Microbiol; 1990 May; 32(1):63-8. PubMed ID: 1971311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunit.
    Mooi FR; ter Avest A; van der Heide HG
    FEMS Microbiol Lett; 1990 Jan; 54(1-3):327-31. PubMed ID: 1969830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.
    Li ZM; Brennan MJ; David JL; Carter PH; Cowell JL; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3184-8. PubMed ID: 2903125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.